Neurocrine Biosciences | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 350.71B 19.93B 2025-05
Agios Pharmaceuticals USD 1.72B 21M 2025-05
ALKERMES USD 5.14B 301M 2025-05
Alnylam Pharmaceuticals USD 33.46B 1.67B 2025-05
Amgen USD 150.93B 16.57B 2025-05
Biogen USD 17.99B 2.04B 2025-05
BioMarin Pharmaceutical USD 11.82B 1.73B 2025-05
Cytokinetics USD 5.55B 661M 2024-12
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 128.54B 11.15B 2025-05
Halozyme Therapeutics USD 6.08B 1.17B 2024-12
Incyte USD 14.04B 2.32B 2025-05
Ionis Pharmaceuticals USD 4.88B 80M 2025-05
Neurocrine Biosciences USD 10.91B 2.91B 2025-05
Pfizer USD 135.96B 7.76B 2025-05
Prothena USD 745M 155M 2024-12
Regeneron Pharmaceuticals USD 66.69B 2.65B 2025-05
Repligen USD 7.89B 740M 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 130.09B 26.64B 2025-05



Neurocrine Biosciences Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.